Skip to main content
CYH
NYSE Industrial Applications And Services

CHS 10-Q: Negative $55M Operating Cash Flow and $155M Cash After $86M Q3 Loss

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.41
Mkt Cap
$339.833M
52W Low
$2.19
52W High
$4.33
52W Position info
10% above low
Off High info
44% below high
Rel. Volume info
6.3× avg
Market data snapshot near publication time

CYH is trading near its 52-week low of $2.19 (10% above the low) on elevated volume (6.3× avg).

Summary

CHS's Q3 10-Q confirms the previously reported $86 million quarterly loss and adds the detail that matters: nine-month operating cash flow turned negative $55 million and cash dropped to $155 million, against $9.6 billion of debt.


Key Events · Earnings and Guidance · CYH

  • Q3 Loss Confirmed at $86M

    Net loss attributable to CHS stockholders was $86 million, or $0.63 per share, on $2.757 billion of revenue, versus $130 million of income a year earlier.

  • Operating Cash Flow Turns Negative

    Nine-month operating cash flow was negative $55 million versus positive $277 million in 2025, driven by a $113 million receivables build and $650 million of interest paid.

  • Cash Falls to $155M

    Cash and equivalents dropped to $155 million at September 30, 2026 from $260 million at December 31, 2025, with $745 million of undrawn ABL capacity as a backstop.

  • Debt Cut With Divestiture Proceeds

    Total debt fell to $9.586 billion from $10.396 billion, including a $600 million tender offer that retired $368 million of 4.750% 2031 notes and $231 million of 10.875% 2032 notes.


Analysis · CYH · Industrial Applications And Services

The headline loss was already public, but the 10-Q reveals a cash position worse than the income statement implies: nine-month operating cash flow swung to negative $55 million from positive $277 million, and cash fell to $155 million from $260 million at year-end. Against $9.6 billion of debt and $620 million of nine-month interest expense, that thin cash cushion is the real story. Management points to $745 million of undrawn ABL capacity and $1.2 billion of divestiture proceeds already used to retire about $600 million of notes, so near-term liquidity is covered—but the business is now burning cash while it shrinks through hospital sales.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CYH was trading at $2.41 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $339.8M. The 52-week trading range was $2.19 to $4.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CYH - Latest Insights

CYH
Nov 09, 2026, 7:00 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $2.26
Real-time Price: $2.21 info
Change: -$0.050 (-2%) info
Market Cap: $315.9M info
CYH
Oct 28, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.30
Real-time Price: $2.21 info
Change: -$0.0915 (-4%) info
Market Cap: $315.9M info
CYH
Oct 28, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.66
Real-time Price: $2.21 info
Change: -$0.450 (-17%) info
Market Cap: $315.9M info
CYH
Jul 23, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.72
Real-time Price: $2.21 info
Change: -$0.510 (-19%) info
Market Cap: $315.9M info
CYH
Jul 22, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.00
Real-time Price: $2.21 info
Change: -$0.790 (-26%) info
Market Cap: $315.9M info